2026 Q2 Portfolio Activity
In 2026 Q2, Integral Health Asset Management, LLC maintained a portfolio of 121 distinct positions. The most significant new addition was ABBOTT LABORATORIES, now representing 1.43% of the total fund value. They heavily accumulated shares in REVOLUTION MEDICINES INC, increasing the position by 200.0%. The fund also reduced its exposure to REVOLUTION MEDICINES INC by 80.0%.
Position History
hover any row below to update
Loading…
Total Positions
121
Quarter
2026 Q2
Top Holding
RVMD (11.1%)
Top 10 Concentration
44.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 121
Integral Health Asset Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 11.10% | 6.98% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
1,500,000 | $280,920,000 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 6.74% | 11.73% |
#2
1
Prev: #1
|
6.2 |
—
|
100,000 | 6.7% |
P
S
|
1,600,000 | $170,592,000 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 5.38% | 5.04% |
#3
Prev: #3
|
4.2 |
—
|
no change | no change |
P
S
|
1,600,000 | $136,304,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 4.49% | 0.52% |
#4
51
Prev: #55
|
5.3 |
—
|
950,000 | 633.3% |
P
S
|
1,100,000 | $113,795,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.21% | 2.41% |
#5
8
Prev: #13
|
4.3 |
—
|
400,000 | 25.0% |
P
S
|
2,000,000 | $81,260,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.97% | 3.08% |
#6
1
Prev: #7
|
3.2 |
—
|
150,000 | 9.4% |
P
S
|
1,750,000 | $75,092,500 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 2.90% | 0.28% |
#7
67
Prev: #74
|
4.2 |
—
|
265,000 | 757.1% |
P
S
|
300,000 | $73,431,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 2.81% | 2.73% |
#8
Prev: #8
|
3.1 |
—
|
30,000 | 11.1% |
P
S
|
300,000 | $71,268,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.80% | 2.65% |
#9
Prev: #9
|
2.1 |
—
|
no change | no change |
P
S
|
2,000,000 | $70,780,000 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 2.41% | 2.50% |
#10
1
Prev: #11
|
1.5 |
—
|
-50,000 | -8.3% |
P
S
|
550,000 | $61,066,500 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 2.23% | 0.65% |
#11
27
Prev: #38
|
3.9 |
—
|
455,000 | 267.6% |
P
S
|
625,000 | $56,537,500 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
PUT
REVOLUTION MEDI...
|
PUT Option | 2.22% | 3.49% |
#12
8
Prev: #4
|
0.9 |
—
|
-450,000 | -60.0% |
P
S
|
300,000 | $56,184,000 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALHC
ALIGNMENT HEALT...
|
Healthcare | 1.88% | 2.17% |
#13
3
Prev: #16
|
0.8 |
—
|
-575,000 | -22.3% |
P
S
|
2,000,000 | $47,620,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 1.78% | 2.45% |
#14
2
Prev: #12
|
1.2 |
—
|
-75,000 | -17.6% |
P
S
|
350,000 | $44,975,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DGX
QUEST DIAGNOSTI...
|
Healthcare | 1.67% | 0.56% |
#15
31
Prev: #46
|
3.7 |
—
|
140,000 | 233.3% |
P
S
|
200,000 | $42,390,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.64% | 0.70% |
#16
18
Prev: #34
|
1.7 |
—
|
no change | no change |
P
S
|
900,000 | $41,454,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.63% | 1.18% |
#17
4
Prev: #21
|
3.7 |
—
|
250,000 | 50.0% |
P
S
|
750,000 | $41,250,000 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.52% | 1.65% |
#18
Prev: #18
|
3.6 |
—
|
350,000 | 63.6% |
P
S
|
900,000 | $38,412,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.52% | 2.55% |
#19
9
Prev: #10
|
0.6 |
—
|
-700,000 | -56.0% |
P
S
|
550,000 | $38,357,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 1.43% | — |
#20
Prev: #—
|
4.1 |
—
|
400,000 | — |
NEW
|
400,000 | $36,296,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.40% | — |
#21
Prev: #—
|
4.1 |
—
|
85,000 | — |
NEW
|
85,000 | $35,328,550 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LFST
LIFESTANCE HEAL...
|
Healthcare | 1.27% | 1.31% |
#22
3
Prev: #19
|
0.5 |
—
|
-1,300,000 | -30.2% |
P
S
|
3,000,000 | $32,130,000 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVS
NOVARTIS AG
|
Healthcare | 1.24% | 1.83% |
#23
6
Prev: #17
|
0.5 |
—
|
-50,000 | -20.0% |
P
S
|
200,000 | $31,344,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.23% | 0.45% |
#24
36
Prev: #60
|
3.5 |
—
|
550,000 | 122.2% |
P
S
|
1,000,000 | $31,260,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 1.22% | — |
#25
Prev: #—
|
4.0 |
—
|
165,000 | — |
NEW
|
165,000 | $30,868,200 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.14% | — |
#26
Prev: #—
|
4.0 |
—
|
325,000 | — |
NEW
|
325,000 | $28,853,500 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 1.14% | — |
#27
Prev: #—
|
4.0 |
—
|
600,000 | — |
NEW
|
600,000 | $28,764,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.02% | 0.36% |
#28
41
Prev: #69
|
2.9 |
—
|
150,000 | 37.5% |
P
S
|
550,000 | $25,872,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.00% | 0.95% |
#29
3
Prev: #26
|
1.4 |
—
|
no change | no change |
P
S
|
150,000 | $25,281,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.99% | 3.14% |
#30
24
Prev: #6
|
0.4 |
—
|
-45,000 | -52.9% |
P
S
|
40,000 | $24,941,600 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
CALL
IONIS PHARMACEU...
|
CALL Option | 0.94% | — |
#31
Prev: #—
|
3.9 |
—
|
300,000 | — |
NEW
|
300,000 | $23,787,000 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.85% | 0.53% |
#32
18
Prev: #50
|
3.3 |
—
|
40,000 | 66.7% |
P
S
|
100,000 | $21,606,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.84% | — |
#33
Prev: #—
|
3.8 |
—
|
375,000 | — |
NEW
|
375,000 | $21,303,750 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 0.83% | 0.45% |
#34
25
Prev: #59
|
3.3 |
—
|
65,000 | 52.0% |
P
S
|
190,000 | $21,078,600 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 0.83% | 0.90% |
#35
8
Prev: #27
|
0.8 |
—
|
-25,000 | -14.3% |
P
S
|
150,000 | $20,964,000 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.81% | 0.85% |
#36
6
Prev: #30
|
2.8 |
—
|
500,000 | 35.7% |
P
S
|
1,900,000 | $20,577,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.81% | 0.98% |
#37
13
Prev: #24
|
1.3 |
—
|
no change | no change |
P
S
|
275,000 | $20,482,000 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.78% | 0.85% |
#38
9
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
40,000 | $19,869,200 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 0.78% | 0.84% |
#39
8
Prev: #31
|
0.8 |
—
|
-100,000 | -12.5% |
P
S
|
700,000 | $19,698,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 0.76% | 1.05% |
#40
18
Prev: #22
|
0.3 |
—
|
-25,000 | -33.3% |
P
S
|
50,000 | $19,336,500 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 0.76% | 1.02% |
#41
18
Prev: #23
|
0.3 |
—
|
-350,000 | -53.8% |
P
S
|
300,000 | $19,257,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.72% | 0.54% |
#42
6
Prev: #48
|
2.8 |
—
|
300,000 | 42.9% |
P
S
|
1,000,000 | $18,320,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.71% | 0.66% |
#43
6
Prev: #37
|
1.3 |
—
|
no change | no change |
P
S
|
15,000 | $17,991,450 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.64% | 0.90% |
#44
16
Prev: #28
|
0.3 |
—
|
-100,000 | -33.3% |
P
S
|
200,000 | $16,302,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVST
ENVISTA HOLDING...
|
Healthcare | 0.62% | 0.42% |
#45
20
Prev: #65
|
3.2 |
—
|
250,000 | 71.4% |
P
S
|
600,000 | $15,810,000 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 0.62% | — |
#46
Prev: #—
|
3.7 |
—
|
200,000 | — |
NEW
|
200,000 | $15,646,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WAT
WATERS CORP
|
Healthcare | 0.59% | — |
#47
Prev: #—
|
3.7 |
—
|
40,000 | — |
NEW
|
40,000 | $15,001,600 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 0.58% | 0.46% |
#48
10
Prev: #58
|
2.7 |
—
|
30,000 | 20.0% |
P
S
|
180,000 | $14,801,400 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVO
CALL
NOVO-NORDISK A ...
|
CALL Option | 0.57% | — |
#49
Prev: #—
|
3.7 |
—
|
300,000 | — |
NEW
|
300,000 | $14,382,000 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FBRX
FORTE BIOSCIENC...
|
Healthcare | 0.57% | 0.19% |
#50
29
Prev: #79
|
3.2 |
—
|
525,000 | 350.0% |
P
S
|
675,000 | $14,343,750 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 121 holdings